Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition
暂无分享,去创建一个
[1] J. King,et al. Thermolabile folding intermediates: inclusion body precursors and chaperonin substrates , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] E. D. de Koning,et al. Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro. , 1995, Biochemistry.
[3] P. Pedersen,et al. Defective protein folding as a basis of human disease. , 1995, Trends in biochemical sciences.
[4] J. King,et al. In vitro folding of phage P22 coat protein with amino acid substitutions that confer in vivo temperature sensitivity. , 1995, Biochemistry.
[5] W. Tap,et al. Specificity in chaperonin-mediated protein folding , 1995, Nature.
[6] J. King,et al. Multimeric intermediates in the pathway to the aggregated inclusion body state for P22 tailspike polypeptide chains , 1995, Protein science : a publication of the Protein Society.
[7] P. Lansbury,et al. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[8] Daniel I. C. Wang,et al. Molecular thermodynamic model for Helix‐Helix docking and protein aggregation , 1995 .
[9] J. King,et al. Selective in vivo rescue by GroEL/ES of thermolabile folding intermediates to phage P22 structural proteins. , 1994, The Journal of biological chemistry.
[10] J. King,et al. Intracellular trapping of a cytoplasmic folding intermediate of the phage P22 tailspike using iodoacetamide. , 1994, The Journal of biological chemistry.
[11] R. Wetzel,et al. Inclusion body formation by interleukin‐1β depends on the thermal sensitivity of a folding intermediate , 1994, FEBS letters.
[12] S. Steinbacher,et al. Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer. , 1994, Science.
[13] R. Wetzel. Mutations and off-pathway aggregation of proteins. , 1994, Trends in biotechnology.
[14] R. Seckler,et al. Mechanism of phage P22 tailspike protein folding mutations , 1993, Protein science : a publication of the Protein Society.
[15] J. King,et al. Folding of the phage P22 coat protein in vitro. , 1993, Biochemistry.
[16] J. King,et al. Temperature-sensitive mutations and second-site suppressor substitutions affect folding of the P22 tailspike protein in vitro. , 1993, The Journal of biological chemistry.
[17] J. Cleland. Protein folding : in vivo and in vitro , 1993 .
[18] K. Dill,et al. Aggregation and denaturation of apomyoglobin in aqueous urea solutions. , 1993, Biochemistry.
[19] R. Seckler,et al. Interactions of phage P22 tailspike protein with GroE molecular chaperones during refolding in vitro. , 1993, The Journal of biological chemistry.
[20] P. Lansbury,et al. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. , 1992, Biochemistry.
[21] D. I. Wang,et al. Polyethylene glycol enhanced refolding of bovine carbonic anhydrase B. Reaction stoichiometry and refolding model. , 1992, The Journal of biological chemistry.
[22] G. Georgiou,et al. Inclusion Bodies and Recovery of Proteins from the Aggregated State , 1991 .
[23] B Fane,et al. Global suppression of protein folding defects and inclusion body formation. , 1991, Science.
[24] C. C. Tomich,et al. Site-directed mutagenesis to probe protein folding: evidence that the formation and aggregation of a bovine growth hormone folding intermediate are dissociable processes. , 1991, Biochemistry.
[25] R. Jaenicke,et al. A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. , 1991, Biochemistry.
[26] J. King,et al. Properties of monoclonal antibodies selected for probing the conformation of wild type and mutant forms of the P22 tailspike endorhamnosidase. , 1990, The Journal of biological chemistry.
[27] J. King,et al. Protein Folding Intermediates and Inclusion Body Formation. , 1989, Bio/Technology.
[28] D. Brems,et al. Stabilization of an associated folding intermediate of bovine growth hormone by site-directed mutagenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. King,et al. Formation of aggregates from a thermolabile in vivo folding intermediate in P22 tailspike maturation. A model for inclusion body formation. , 1988, The Journal of biological chemistry.
[30] M. Desmadril,et al. Quasi-irreversibility in the unfolding-refolding transition of phosphoglycerate kinase induced by guanidine hydrochloride. , 1987, European journal of biochemistry.
[31] F. Marston. The purification of eukaryotic polypeptides synthesized in Escherichia coli. , 1986, The Biochemical journal.
[32] E. W. Kauffman,et al. Characterization of an associated equilibrium folding intermediate of bovine growth hormone. , 1986, Biochemistry.
[33] M. Saraiva,et al. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). , 1984, The Journal of clinical investigation.
[34] J. King,et al. Genetic analysis of the folding pathway for the tail spike protein of phage P22. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. King,et al. Trimeric intermediate in the in vivo folding and subunit assembly of the tail spike endorhamnosidase of bacteriophage P22. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. King,et al. Scaffolding Proteins and the Genetic Control of Virus Shell Assembly , 1980, The Quarterly review of biology.
[37] R. Jaenicke,et al. Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. , 1979, Biochemistry.
[38] M. Goldberg,et al. Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centers. , 1974, European journal of biochemistry.
[39] J. Cleland. Impact of protein folding on biotechnology , 1993 .
[40] R. Jaenicke,et al. [12]Refolding and association of oligomeric proteins , 1986 .
[41] J. King,et al. Mutational analysis of protein folding pathways: the P22 tailspike endorhamnosidase. , 1986, Methods in enzymology.
[42] R. G. Shea. Genetic identification of phage P22 antigens and their structural location. , 1977 .